GB0109287D0 - Therapeutic benzamide derivatives - Google Patents

Therapeutic benzamide derivatives

Info

Publication number
GB0109287D0
GB0109287D0 GBGB0109287.3A GB0109287A GB0109287D0 GB 0109287 D0 GB0109287 D0 GB 0109287D0 GB 0109287 A GB0109287 A GB 0109287A GB 0109287 D0 GB0109287 D0 GB 0109287D0
Authority
GB
United Kingdom
Prior art keywords
benzamide derivatives
therapeutic
therapeutic benzamide
derivatives
benzamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0109287.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0109287.3A priority Critical patent/GB0109287D0/en
Publication of GB0109287D0 publication Critical patent/GB0109287D0/en
Priority to PCT/EP2002/004061 priority patent/WO2002083658A1/en
Priority to JP2002581414A priority patent/JP2004525964A/en
Priority to EP02732605A priority patent/EP1383753A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
GBGB0109287.3A 2001-04-12 2001-04-12 Therapeutic benzamide derivatives Ceased GB0109287D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB0109287.3A GB0109287D0 (en) 2001-04-12 2001-04-12 Therapeutic benzamide derivatives
PCT/EP2002/004061 WO2002083658A1 (en) 2001-04-12 2002-04-11 Piperazine-benzamide derivatives useful as apob-100 and/or mtp inhibitor
JP2002581414A JP2004525964A (en) 2001-04-12 2002-04-11 Piperazine-benzamide derivatives useful as APOB-100 and / or MTP inhibitors
EP02732605A EP1383753A1 (en) 2001-04-12 2002-04-11 Piperazine-benzamide derivatives useful as apob-100 and/or mtp inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0109287.3A GB0109287D0 (en) 2001-04-12 2001-04-12 Therapeutic benzamide derivatives

Publications (1)

Publication Number Publication Date
GB0109287D0 true GB0109287D0 (en) 2001-05-30

Family

ID=9912827

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0109287.3A Ceased GB0109287D0 (en) 2001-04-12 2001-04-12 Therapeutic benzamide derivatives

Country Status (4)

Country Link
EP (1) EP1383753A1 (en)
JP (1) JP2004525964A (en)
GB (1) GB0109287D0 (en)
WO (1) WO2002083658A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1880304B (en) 2001-06-28 2010-11-24 辉瑞产品公司 Triamide-substituted indoles, benzofuranes and benzothiophenes
UA83510C2 (en) * 2003-12-09 2008-07-25 Янссен Фармацевтика Н.В. N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b
JP5644106B2 (en) * 2007-05-17 2014-12-24 味の素株式会社 Method for measuring the activity of lipid modifying enzymes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9826412D0 (en) * 1998-12-03 1999-01-27 Glaxo Group Ltd Chemical compounds
GB0013346D0 (en) * 2000-06-01 2000-07-26 Glaxo Group Ltd Therapeutic benzamide derivatives

Also Published As

Publication number Publication date
WO2002083658A1 (en) 2002-10-24
JP2004525964A (en) 2004-08-26
EP1383753A1 (en) 2004-01-28

Similar Documents

Publication Publication Date Title
GB0013383D0 (en) Therapeutic benzamide derivatives
EP1377295A4 (en) Carboxamide derivatives as therapeutic agents
GB0113841D0 (en) Therapeutic agents
GB0013346D0 (en) Therapeutic benzamide derivatives
GB0114867D0 (en) Therapeutic agents
GB0108930D0 (en) Therapeutic agents
GB0113839D0 (en) Therapeutic agents
GB0113842D0 (en) Therapeutic agents
GB0111191D0 (en) Therapeutic agents
GB0113843D0 (en) Therapeutic agents
AU2002358574A1 (en) Therapeutic benzamide derivatives
AU2002358076A1 (en) Therapeutic benzamide derivatives
GB0109287D0 (en) Therapeutic benzamide derivatives
GB0119370D0 (en) Therapeutic agent
GB0108982D0 (en) Therapeutic agents
GB0128122D0 (en) Therapeutic use
GB0123991D0 (en) New therapeutic use
GB0013386D0 (en) Therapeutic benzamide derivatives
GB0013389D0 (en) Therapeutic benzamide derivatives
GB0013377D0 (en) Therapeutic benzamide derivatives
GB0013380D0 (en) Therapeutic benzamide derivatives
GB0013387D0 (en) Therapeutic benzamide derivatives
GB0108973D0 (en) Therapeutic agents
GB0128128D0 (en) Therapeutic use
GB0128089D0 (en) Therapeutic use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)